DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.

Author(s): Umut S, Tutluoglu B, Aydin Tosun G, Musellim B, Erk M, Yildirim N, Vahapoglu H, Yilmaz N, Arseven O, Turker H, Erelel M, Ilvan A, Goylusun V, Yilmaz Kuyucu T, Kosar F, Soysal F, Gur A, Unutmaz S, Ozturk S, Akman M

Affiliation(s): Istanbul University Cerrahpasa School of Medicine, Dept. of Pulmonology, Turkey.

Publication date & source: 1999-06, J Chemother., 11(3):211-4.

Publication type: Clinical Trial; Randomized Controlled Trial

Acute exacerbations, most of which are due to lower respiratory tract infections, cause great morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD) and most of these are due to lower respiratory tract infections. The aim of this study was to determine the causative organism and the effects of azithromycin, ampicillin sulbactam (sultamicillin), ciprofloxacin and cefaclor monohydrate therapy in COPD. One hundred and six patients with COPD in acute exacerbation were randomized into four groups for empiric antibiotic treatment following lung function tests and sputum examination. The most common strains isolated from sputum were Haemophilus influenzae (30.8%), Streptoccocus pneumoniae (12%) and Moraxella catarrhalis (7.7%). Azithromycin, sultamicillin, ciprofloxacin and cefaclor monohydrate were found to be effective in treating COPD exacerbations.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017